PEDS-06
(PEDS) Best Pediatric Abstracts
Pediatric BMT Program
Grapevine A+C (Gaylord Texan)
Outcomes of Allogeneic Cord Blood Transplantation for Leukodystrophies; A Joint Study of Eurocord and "Inborn Errors WP-EBMT"
Janna Hol, University Medical Center Utrecht;
Annalisa Ruggeri, MD, Eurocord International Registry;
Vanderson Geraldo Rocha, MD, PhD, Oxford University Hospitals;
Gerard Michel, MD, La Timone Hospital;
Mouhab Ayas, MD, King Faisal Specialist Hospital & Research Center;
Tracey O'Brien, MD, Centre for Children's Cancer, Sydney Children's Hospital;
Gergely Krivan, MD, St. Laszlo Hospital;
Victoria Bordon, MD, Ghent University Hospital;
Rik Schots, MD, PhD, University Hospital Brussels;
Attilio Rovelli, MD, San Gerardo University Hospital;
Izaskun Elorza, MD, Hospital Vall D'Hebron;
Jose Moraleda, MD, PhD, Hospital Universitario Vergen de la Arrixaca;
Peter John Shaw, MD, Children's Hospital At Westmead;
Marleen Renard, MD, University Hospital Gasthuisberg;
Karl-Walter Sykora, MD, Hannover Medical School;
Reuven Or, MD, Hadassah University Hospital;
Tsila Zuckerman, MD, Rambam Medical Center;
Manuel Abecasis, MD PhD, Instituto Portugues de Oncologia, BMT Unit;
Robbert Bredius, MD, PhD, Leiden University Medical Center;
M. Akif Yesilipek, MD, Akdeniz University Medical School;
Miguel Angel Diaz, MD, PhD, Hospital Nino Jesus;
Andrew Gennery, MD, Newcastle University;
Eliane Gluckman, MD RFCP, Eurocord;
Jaap-Jan Boelens, MD, PhD, University Medical Center Utrecht
Quantitative Monitoring of Minimal Residual Disease after Allogeneic Stem Cell Transplantation in Relapsed Childhood ALL Allows the Identification of Impending Relapse – Results of the ALL BFM SCT 2003 Trial
Peter Bader, MD, Klinik für Kinder und Jugendmedizin;
Hermann Kreyenberg, Klinik für Kinder und Jugendmedizin;
Arend von Stackelberg, Chldren Hospital Charite;
Cornelia Eckert, University Children's Hospital Charite;
Roland Meisel, University Hospital;
Ulrike Poetschger, St. Anna Children's Cancer Research Institute;
Daniel Stachel, MD, Kinderklinik der Universitat Munchen;
Martin Schrappe, University Hospital Schleswig-Holstein;
Andre Schrauder, University Hospital Kiel;
Ansgar Schulz, Universitatsklinikum Ulm Klinik fur Kinder;
Peter Lang, MD, PhD, University Children's Hospital Tuebingen;
Ingo Mueller, Universitats-Kinderlinik Hamburg;
Michael Albert, Dr. von Haunersches Kinderspital;
Thomas E Klingebiel, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Christina Peters, MD, PhD, St. Anna Children's Hospital
Allogeneic Stem Cell Transplant Offers Cure for Intractable Childhood Enteropathy
Austen J. J. Worth, MD, PhD, Great Ormond Street Hospital for Children;
Zohreh Nademi, Dr, Great North Childrens Hospital;
Jochen Kammermeier, Dr, Great Ormond Street Hospital;
Su Bunn, Dr, Great North Childrens Hospital;
Robert Chiesa, Dr, Great Ormond Street Hospital;
Andrew Cant, MD, Newcastle General Hospital;
Sophie Hambleton, Dr, Great North Childrens Hospital;
Neil Shah, Great Ormond Street Hospital;
Mary Slatter, Newcastle upon Tyne Hospitals NHS Foundation Trust;
Kanchan Rao, MD, MRCPCH, Great Ormond Street Hospital;
Andrew Gennery, MD, Newcastle University;
Mamoun Elawad, Dr, Great Ormond Street Hospital;
Persis Amrolia, MD, PhD, Great Ormond St Children`s Hospital;
Paul Veys, MD, Great Ormond Street Hospital for Children
Reduced Intensity Conditioning Regimen Combined with Single Unit Cord Blood Transplantation Is Effective and Safe for Children with Inherited Metabolic Disorders and Combined Immunodeficiency Diseases
Mark Vander Lugt, MD, Children's Hospital of Pittsburgh of UPMC;
Xiaohua Chen, Ph.D, Children's Hospital of Pittsburgh of UPMC;
Randy Windreich, MD, Children's Hospital of Pittsburgh of UPMC;
Rakesh K Goyal, MD, Children's Hospital of Pittsburgh of UPMC;
Elizabeth Stenger, MD, Children's Hospital of Pittsburgh of UPMC;
Maria Escolar, MD, Children's Hospital of Pittsburgh of UPMC;
Paul Szabolcs, MD, Children's Hospital of Pittsburgh of UPMC
Transplant Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia: The Cibmtr Experience
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center;
Mary Eapen, MBBS, MS, CIBMTR/Medical College of Wisconsin;
Mei-Jie Zhang, PhD, Medical College of Wisconsin;
Wensheng He, PhD, MS, Medical College of Wisconsin;
Adriana Seber, MD, Instituto de Oncologia Pediatrica;
Carrie L. Kitko, MD, University of Michigan;
Gregory A. Hale, MD, All Children's Hospital;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center
Interplay of Recipient-Donor Matching for HLA, Race/Ethnicity and Gender on Long Term Outcomes in 365 Pediatric Recipients of Single 4/6 Matched Unrelated Cord Blood Transplantation (UCBT) after Myeloablative Therapy
Vinod K. Prasad, MD, Duke University Medical Center;
Adam Mendizabal, MS, The EMMES Corporation;
Kristin Page, MD, Duke University Medical Center;
Suhag Parikh, MD, Duke University Medical Center;
Jessica Wishnew, MD, Duke University Medical Center;
Timothy A Driscoll, MD, Duke University Medical Center;
Paul L. Martin, MD, PhD, Duke University Medical Center;
Joanne Kurtzberg, MD, Duke University Medical Center
